BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 1309726)

  • 21. High Epstein-Barr virus (EBV) susceptibility of both lymphoblastoid and lymphoma cell lines derived from a Japanese patient with EBV genome-positive Burkitt's lymphoma.
    Okano M; Aya T; Mizuno F; Takada K; Osato T
    Tohoku J Exp Med; 1993 Jun; 170(2):71-9. PubMed ID: 8266328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
    Lacerda JF; Ladanyi M; Louie DC; Fernandez JM; Papadopoulos EB; O'Reilly RJ
    J Exp Med; 1996 Mar; 183(3):1215-28. PubMed ID: 8642263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus (EBV) and human hematopoietic cell lines: a review.
    Tatsumi E
    Hum Cell; 1992 Mar; 5(1):79-86. PubMed ID: 1329932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transfection of the c-myc oncogene into normal Epstein-Barr virus-harboring B cells results in new phenotypic and functional features resembling those of Burkitt lymphoma cells and normal centroblasts.
    Cutrona G; Ulivi M; Fais F; Roncella S; Ferrarini M
    J Exp Med; 1995 Feb; 181(2):699-711. PubMed ID: 7836923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines.
    Gibbons DL; Rowe M; Cope AP; Feldmann M; Brennan FM
    Eur J Immunol; 1994 Aug; 24(8):1879-85. PubMed ID: 8056047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deregulated c-myc expression in Epstein-Barr-virus-immortalized B-cells induces altered growth properties and surface phenotype but not tumorigenicity.
    Hotchin NA; Allday MJ; Crawford DH
    Int J Cancer; 1990 Mar; 45(3):566-71. PubMed ID: 2155186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the Epstein-Barr virus (EBV)-encoded membrane protein LMP1 impairs the in vitro growth, clonability and tumorigenicity of an EBV-negative Burkitt lymphoma line.
    Cuomo L; Ramquist T; Trivedi P; Wang F; Klein G; Masucci MG
    Int J Cancer; 1992 Jul; 51(6):949-55. PubMed ID: 1322379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A monoclonal antibody with anti-Burkitt lymphoma specificity. I. Analysis of human haematopoietic and lymphoid cell lines.
    Wiels J; Lenoir GM; Fellous M; Lipinski M; Salomon JC; Tetaud C; Tursz T
    Int J Cancer; 1982 Jun; 29(6):653-8. PubMed ID: 6286514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of type IV collagenase correlates with the invasion of human lymphoblastoid cell lines and pathogenesis in SCID mice.
    Hendrix MJ; Seftor EA; Grogan TM; Seftor RE; Hersh EM; Boyse EA; Liotta LA; Stetler-Stevenson W; Ray CG
    Mol Cell Probes; 1992 Feb; 6(1):59-65. PubMed ID: 1312223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL6 and IL6 receptor expression in Burkitt's lymphoma and lymphoblastoid cell lines: promotion of IL6 receptor expression by EBV.
    Klein SC; Jücker M; Abts H; Tesch H
    Hematol Oncol; 1995; 13(3):121-30. PubMed ID: 7622142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of interleukin 10 in B lymphocytes of different origin.
    Finke J; Ternes P; Lange W; Mertelsmann R; Dölken G
    Leukemia; 1993 Nov; 7(11):1852-7. PubMed ID: 7694007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation of a normal B cell subset with a Burkitt-like phenotype and transformation in vitro with Epstein-Barr virus.
    Gregory CD; Edwards CF; Milner A; Wiels J; Lipinski M; Rowe M; Tursz T; Rickinson AB
    Int J Cancer; 1988 Aug; 42(2):213-20. PubMed ID: 2841246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eradication of latent Epstein-Barr virus by hydroxyurea alters the growth-transformed cell phenotype.
    Chodosh J; Holder VP; Gan YJ; Belgaumi A; Sample J; Sixbey JW
    J Infect Dis; 1998 May; 177(5):1194-201. PubMed ID: 9593003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regression of experimental Burkitt's lymphoma induced by Epstein-Barr virus-immortalized human B cells.
    Tosato G; Sgadari C; Taga K; Jones KD; Pike SE; Rosenberg A; Sechler JM; Magrath IT; Love LA; Bhatia K
    Blood; 1994 Feb; 83(3):776-84. PubMed ID: 8298139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retinoic acid induces persistent, RARalpha-mediated anti-proliferative responses in Epstein-Barr virus-immortalized b lymphoblasts carrying an activated C-MYC oncogene but not in Burkitt's lymphoma cell lines.
    Cariati R; Zancai P; Quaia M; Cutrona G; Giannini F; Rizzo S; Boiocchi M; Dolcetti R
    Int J Cancer; 2000 May; 86(3):375-84. PubMed ID: 10760826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the APO-1 antigen in Burkitt lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotype.
    Falk MH; Trauth BC; Debatin KM; Klas C; Gregory CD; Rickinson AB; Calender A; Lenoir GM; Ellwart JW; Krammer PH
    Blood; 1992 Jun; 79(12):3300-6. PubMed ID: 1375849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterotransplantation of human Burkitt's lymphoma cell lines in athymic nude mice: tumor-host relationships.
    McManaway ME; Marti GE; Tosato G; Liu AK; al-Nasser AA; Kiwanuka J; Magrath IT
    Pathobiology; 1993; 61(3-4):164-72. PubMed ID: 8216838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EBV peptide epitope sensitization restores human cytotoxic T cell recognition of Burkitt's lymphoma cells. Evidence for a critical role for ICAM-2.
    Khanna R; Burrows SR; Suhrbier A; Jacob CA; Griffin H; Misko IS; Sculley TB; Rowe M; Rickinson AB; Moss DJ
    J Immunol; 1993 Jun; 150(11):5154-62. PubMed ID: 7684421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines.
    Masucci MG; Torsteindottir S; Colombani J; Brautbar C; Klein E; Klein G
    Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4567-71. PubMed ID: 3037521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of Epstein-Barr virus latent gene expression on the apoptosis-inducing effects of cortisone and 2-chlorodeoxyadenosine (2-CDA) in B-cell lines.
    Röth A; Pfaff P; Lange W; Finke J
    Cytokines Mol Ther; 1996 Mar; 2(1):21-8. PubMed ID: 9384686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.